Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.

Multiple sclerosis (MS) and other T cell-mediated autoimmune diseases develop in individuals carrying a complex susceptibility trait, probably following exposure to various environmental triggers. Owing to the presumed weak influence of single genes on disease predisposition and the recognized genetic heterogeneity of autoimmune disorders in humans, candidate gene searches in MS have been difficult. In an attempt to identify molecular markers indicative of disease status rather than susceptibility genes for MS, we show that gene expression profiling of peripheral blood mononuclear cells by cDNA microarrays can distinguish MS patients from healthy controls. Our findings support the concept that the activation of autoreactive T cells is of primary importance for this complex organ-specific disorder and prompt further investigations on gene expression in peripheral blood cells aimed at characterizing disease phenotypes.

[1]  Wiklund Ra,et al.  First of two parts , 1997 .

[2]  J. Oksenberg,et al.  The complex genetic aetiology of multiple sclerosis. , 2000, Journal of neurovirology.

[3]  J. Witte,et al.  Genetic dissection of complex traits , 1996, Nature Genetics.

[4]  D. Clayton,et al.  Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. , 1996, Brain : a journal of neurology.

[5]  B. Weinshenker,et al.  Multiple sclerosis. , 2000, The New England journal of medicine.

[6]  L. Hood,et al.  Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR Vβ chain locus and HLA class II genes , 1993, Journal of Neuroimmunology.

[7]  W. Leonard,et al.  IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Zimmerman,et al.  Platelet-activating Factor Acetylhydrolases* , 1997, The Journal of Biological Chemistry.

[9]  Short cut to disease genes. , 2001 .

[10]  R. Bassel-Duby,et al.  ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter , 1996, Molecular and cellular biology.

[11]  Paul M. Allen,et al.  Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.

[12]  M. Peter,et al.  Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Hendzel,et al.  Rapid exchange of histone H1.1 on chromatin in living human cells , 2000, Nature.

[14]  A. Bowcock,et al.  Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. , 2001, Human molecular genetics.

[15]  R. Cuesta,et al.  Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. , 1999, Science.

[16]  A. Sadovnick,et al.  Genetics of Multiple Sclerosis , 1998, Seminars in neurology.

[17]  W. Leonard,et al.  IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Lander,et al.  Genetic dissection of complex traits science , 1994 .

[19]  D. McFarlin,et al.  Immunological aspects of demyelinating diseases. , 1992, Annual review of immunology.

[20]  T. Schumacher,et al.  CD27 is required for generation and long-term maintenance of T cell immunity , 2000, Nature Immunology.

[21]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[22]  J. Todd,et al.  Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. , 2001, Immunity.

[23]  Thomas M. Aune,et al.  Cutting Edge: Molecular Portrait of Human Autoimmune Disease1 , 2002, The Journal of Immunology.

[24]  A. Fornace,et al.  Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. , 2002, Immunity.

[25]  C. Pozzilli,et al.  The immune response to Mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis , 1996, Journal of Neuroimmunology.

[26]  N. Risch,et al.  Evidence for genetic basis of multiple sclerosis , 1996, The Lancet.

[27]  J. Klein,et al.  The HLA system. First of two parts. , 2000, The New England journal of medicine.

[28]  L. Staudt,et al.  Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes , 2001, Annals of neurology.

[29]  J. Puck,et al.  Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II , 1999, Cell.

[30]  Edward R. Dougherty,et al.  Small Sample Issues for Microarray-Based Classification , 2001, Comparative and functional genomics.

[31]  Keiji Tanaka,et al.  Conditional Knockdown of Proteasomes Results in Cell-cycle Arrest and Enhanced Expression of Molecular Chaperones Hsp70 and Hsp40 in Chicken DT40 Cells* , 2003, The Journal of Biological Chemistry.

[32]  T. Behrens,et al.  Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.

[33]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[34]  J. Haines,et al.  The genetic epidemiology of multiple sclerosis , 2003, Journal of Neuroimmunology.

[35]  M. Ramanathan,et al.  In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects , 2001, Journal of Neuroimmunology.

[36]  Ash A. Alizadeh,et al.  Individuality and variation in gene expression patterns in human blood , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Martínez-A,et al.  Cell-cycle regulation in immunity, tolerance and autoimmunity. , 2000, Immunology today.

[38]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[39]  D. Brenner,et al.  Prolonged activation of jun and collagenase genes by tumour necrosis factor-α , 1989, Nature.

[40]  L. Staudt,et al.  Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling. , 2003, The Journal of biological chemistry.

[41]  M. Sharief,et al.  Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis , 1991 .

[42]  S. Sawcer,et al.  The Genetic Analysis of Multiple sclerosis in EuropeanS: concepts and design , 2003, Journal of Neuroimmunology.

[43]  N. Risch,et al.  A genetic basis for familial aggregation in multiple sclerosis , 1995, Nature.

[44]  Nicholas J. Hoogenraad,et al.  Molecular Chaperones Hsp90 and Hsp70 Deliver Preproteins to the Mitochondrial Import Receptor Tom70 , 2003, Cell.

[45]  S. Reed,et al.  Mitotic role for the Cdc28 protein kinase of Saccharomyces cerevisiae. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Holstege,et al.  The human T cell transcription factor-1 gene. Structure, localization, and promoter characterization. , 1992, The Journal of biological chemistry.

[47]  Michael L. Bittner,et al.  Strong Feature Sets from Small Samples , 2002, J. Comput. Biol..

[48]  A. Sadovnick,et al.  Genetic epidemiology of multiple sclerosis: A survey , 1994, Annals of neurology.

[49]  N. Risch,et al.  Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. , 1996, Lancet.

[50]  Wing Hung Wong,et al.  Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. , 2003, Physiological genomics.

[51]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[52]  C Dosne Pasqualini,et al.  The HLA system. , 1979, Medicina.